Jump Financial’s Novo Nordisk NVO Stock Holding History

Jump Financial’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.91M	Sell	123,187 -498,206	-80%	-$21.4M	0.05%	451
2026 Q1	$22.8M	Buy	+621,393	New	+$29.4M	0.3%	57
2025 Q4	–	Sell	-22,267	Closed	-$1.24M	–	2192
2025 Q3	$1.24M	Buy	+22,267	New	+$1.3M	0.01%	925
2025 Q2	–	Sell	-4,900	Closed	-$340K	–	2048
2025 Q1	$340K	Buy	+4,900	New	+$405K	﹤0.01%	1243
2024 Q4	–	Sell	-1,698	Closed	-$202K	–	1891
2024 Q3	$202K	Buy	+1,698	New	+$226K	﹤0.01%	1465
2024 Q1	–	Sell	-4,337	Closed	-$449K	–	2172
2023 Q4	$449K	Buy	4,337 +76	+2%	+$7.52K	0.01%	1136
2023 Q3	$387K	Buy	+4,261	New	+$375K	0.01%	1150
2023 Q2	–	Sell	-9,128	Closed	-$726K	–	2052
2023 Q1	$726K	Buy	+9,128	New	+$647K	0.03%	733
2021 Q2	–	Sell	-7,226	Closed	-$244K	–	1307
2021 Q1	$244K	Sell	7,226 -5,388	-43%	-$192K	0.02%	692
2020 Q4	$441K	Buy	+12,614	New	+$436K	0.08%	424

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jump Financial's NVO Position: Q2 2026 in Review

Jump Financial reduced its Novo Nordisk (NVO) stake by 80% in Q2 2026, selling an estimated $21.4M and leaving 123,187 shares worth $5.91M. The position accounts for 0.05% of the portfolio, ranked #451.

Jump Financial first reported a position in NVO in Q4 2020 and has held it in 10 quarters since. The position peaked at $22.8M in Q1 2026. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Jump Financial held 123,187 shares of Novo Nordisk worth $5.91M as of Q2 2026.
Jump Financial sold 498,206 Novo Nordisk shares in Q2 2026, an estimated $21.4M.
Novo Nordisk made up 0.05% of Jump Financial's portfolio in Q2 2026, its #451 holding.
Jump Financial first reported a position in Novo Nordisk in Q4 2020 and has held it in 10 quarters since.
Jump Financial's Novo Nordisk position peaked at $22.8M in Q1 2026.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.